Oliver Distler
Rheumatology
Chemomab
Israel
Biography
Oliver Distler, MD, is Professor of Rheumatology and Director of the Department of Rheumatology at the University of Zurich, Switzerland. His main research interests in systemic sclerosis are the molecular mechanisms leading to microvascular lesions, the biological action of pro-fibrotic mediators, validation of biomarkers, and design of proof-of-concept trials as well as phase III trials. Professor Distler is an editorial board member of several rheumatology journals and Treasurer of EUSTAR. Oliver Distler, MD, is Professor of Rheumatology and Director of the Department of Rheumatology at the University of Zurich, Switzerland. His main research interests in systemic sclerosis are the molecular mechanisms leading to microvascular lesions, the biological action of pro-fibrotic mediators, validation of biomarkers, and design of proof-of-concept trials as well as phase III trials. Professor Distler is an editorial board member of several rheumatology journals and Treasurer of EUSTAR.
Research Interest
Rheumatology
